Does the Selective Progesterone Receptor Modulator Ulipristal Normalize the Uterine Cavity in Women with Leiomyoma?

Gary Levy^*, Nilo Avila, Alicia Armstrong and Lynette Nieman

NIH/NICHD/PRAE, 10 Center Drive, Bldg 10, CRC, Rm 1-3140, Bethesda, MD 20892, USA

^*Corresponding Author: Gary Levy, NIH/NICHD/PRAE, 10 Center Drive, Bldg 10, CRC, Rm 1-3140, Bethesda, MD 20892, USA, Tel: (734)6781980 Email: